Table 3 Logistic regression analysis.

From: The Association of Insulin-dextrose Treatment with Hypoglycemia in Patients with Hyperkalemia

Variable

Univariable

Multivariable d

OR (95% CI)

P value

OR (95% CI)

P value

Age

1.01 (0.99–1.02)

0.230

  

Female sex

0.78 (0.48–1.28)

0.328

  

BMI (per 5 kg/m2)a

0.82 (0.68–0.97)

0.024

0.83 (0.69–0.99)

0.048

MUST score ≥ 2

0.82 (0.43–1.54)

0.528

  

Diabetes mellitus

0.44 (0.27–0.70)

0.001

0.57 (0.33–0.98)

0.043

eGFR < 60 ml/min/1.73m2

2.49 (1.37–4.53)

0.003

2.94 (1.56–5.54)

0.001

Cirrhosis

0.57 (0.16–1.96)

0.369

  

Active malignancy

0.97 (0.51–1.83)

0.916

  

Excess alcohol intake

0.48 (0.17–1.42)

0.185

  

Oral hypoglycemic medication

0.60 (0.35–1.03)

0.066

  

Regular insulin treatment

0.47 (0.25–0.89)

0.021

  

Beta-blockers

0.85 (0.53–1.38)

0.512

  

Renin-angiotensin inhibitors

0.97 (0.59–1.59)

0.899

  

Corticosteroids

0.55 (0.29–1.07)

0.080

  

Sepsis

0.83 (0.39–1.79)

0.637

  

Severe acute kidney injuryb

1.50 (0.78–2.86)

0.221

  

Pre-treatment blood glucosec

0.84 (0.78–0.91)

 < 0.001

0.88 (0.81–0.95)

0.002

Repeat treatment < 6 h

1.13 (0.63–2.03)

0.685

  

Glucose load 12.5 g

1.05 (0.46–2.40)

0.897

  

Treated in Emergency Department

2.60 (1.57–4.30)

 < 0.001

2.53 (1.49–4.31)

0.001

  1. aMissing observations in BMI (n = 11).
  2. bStage 3 AKI and excluding long-term dialysis patients (n = 395).
  3. cMissing observations in pre-treatment blood glucose (n = 22).
  4. dMultiple imputation using chained equations (m = 20) for missing observations.
Back to article page